Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB1 | P46663 | 3/20 | 0.34 |
| ▸ | AVPR1B | P47901 | 1/20 | 0.34 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.34 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3052400 | 0.94 | BDKRB1 (0.35) | BDKRB1AVPR1BPTGER3AVPR1AOPRM1 | |
| SCHEMBL3047591 | 0.90 | AVPR1B (0.37) | BDKRB1AVPR1BAVPR1AOPRM1OPRL1 | |
| SCHEMBL3049716 | 0.89 | PTGER3 (0.34) | BDKRB1AVPR1BPTGER3OPRM1OPRL1 | |
| SCHEMBL3060341 | 0.78 | BDKRB1 (0.53) | BDKRB1AVPR1BAVPR1ASIGMAR1 | |
| SCHEMBL3052539 | 0.77 | BDKRB1 (0.38) | BDKRB1AVPR1BHTR2AHTR2C | |
| SCHEMBL3052564 | 0.77 | OPRD1 (0.38) | BDKRB1OPRM1OPRL1 | |
| SCHEMBL3050887 | 0.76 | MTNR1A (0.40) | — | |
| SCHEMBL13139533 | 0.76 | GAA (0.40) | PTGER3 | |
| SCHEMBL3062326 | 0.75 | BDKRB1 (0.33) | BDKRB1AVPR1BAVPR1ASIGMAR1 | |
| SCHEMBL3057672 | 0.74 | MAPK1 (0.33) | OPRM1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8492559-B2 | Substituted indole compounds | GRUENENTHAL GMBH (DE) | 2013-07-23 | — | — | US | claimed |
| US-20100222324-A1 | Substituted Indole Compounds | GRUENENTHAL GMBH (DE) | 2010-09-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222324-A1 | Substituted Indole Compounds | BDKRB1, BDKRB2, EDNRB | BDKRB1 1/4885AVPR1B 21/4885PTGER3 329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.